STUDY OBJECTIVE: To investigate the correlation between HbA1c and complications after hysterectomies.
DESIGN: Retrospective cohort analysis.
SETTING: Cerner Health Facts (519 million patient encounters from 750 hospitals).
PATIENTS: Patients undergoing laparoscopic±robotic-assisted, vaginal, or abdominal hysterectomy January 2010-November 2018. We included patients with perioperative HbA1c values, including those diagnosed with diabetes or undergoing screening.
INTERVENTIONS: We performed univariable and multivariable logistic regressions with the outcome a composite of any post-op complication. We adjusted for HbA1c as continuous and categorical variables using HbA1c (>8.0% based on guidelines and >8.85% based on ROC analysis from current dataset) as cut-points.
MEASUREMENTS AND MAIN RESULTS: Of 86,420 hysterectomies, 2,693 (3.1%) had non-excluded HbA1c, including 514 (19.1%) with complications and 2,179 (80.9%) without. Median time to complication was 18 days. Patients were 75.2% white, 83.2% in urban hospitals. Route was predominantly minimally invasive: 30.5% laparoscopic, 25.6% vaginal, 43.9% abdominal, with 69.8% adnexa removed. Patients with complications were older (60.5±15.9 vs 58.4±14.2 years, p=.004), more likely from the Southern U.S. (24.5% vs 18.5%, p=.006), used tobacco (26.7% vs 19.0%, p<.001), and were obese (32.3% vs 23.3%, p<.001). Most complications were infectious (87.4%). Higher HbA1c was associated with more complications, whether continuous (p=.03), HbA1c >8.0% (p=.01), or HbA1c >8.85% (p=.001). HbA1c >8.85% optimized test characteristics (sensitivity=.14, specificity=.91, PPV=.27, NPV=.82). Predictive value improved with confounders (AUC=.71-.72), and multivariable analysis demonstrated HbA1c >8.85% increased complications (OR=1.71, 95% CI=1.25-2.32). Obesity (OR=1.31, 95% CI=1.04-1.64) and urogynecological diagnoses including urinary frequency, history of urinary tract infection, and dysuria (OR=2.31, 3.71, 3.98, respectively) also increased complications.
CONCLUSION: HbA1c as a continuous variable impacted complications, so HbA1c reductions will likely decrease complications. For surgeons deciding to proceed with hysterectomy based on preoperative HbA1c, 8.0% and 8.85% are both acceptable cut-points. Multivariable models outperformed HbA1c alone, warranting further research to predict complications.